Does Physical Exercise Ameliorate Chronic Kidney Disease-Related Complications? The Case of Anaemia and Chronic Kidney Disease-Mineral Bone Disorder

被引:0
作者
Aucella, Filippo [1 ]
Amicone, Maria [2 ]
Ys, Aurora del Mar Perez [1 ]
Aucella, Francesco [1 ]
Gatta, Giuseppe [1 ]
Prencipe, Michele Antonio [1 ]
Riccio, Eleonora [2 ]
Capuano, Ivana [2 ]
Pisani, Antonio [2 ]
Battaglia, Yuri [3 ]
机构
[1] Res Hosp Casa Sollievo Sofferenza Fdn, Dept Med Sci, Nephrol & Dialysis Unit, San Giovanni Rotondo, Italy
[2] Feder II Univ, Dept Publ Hlth, Naples, Italy
[3] Univ Verona, Pederzoli Hosp, Dept Med, Nephrol & Dialysis Unit, Verona, Italy
关键词
Physical exercise; Chronic kidney disease; Dialysis; Chronic kidney disease-mineral bone disorder; Anaemia; RENAL-DISEASE; HEMODIALYSIS-PATIENTS; LACTATE; MARKERS; IMPROVES;
D O I
10.1159/000540659
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: Physical exercise (PE) can regulate inflammation, cardiovascular health, sarcopenia, anaemia, and bone health in the chronic kidney disease (CKD) population. Experimental and clinical studies both help us better understand the mechanisms that underlie the beneficial effects of the exercise, especially in renal anaemia and CKD-mineral bone disorders (CKD-MBDs). Here, we summarize this evidence, exploring the biological pathways involved, locally released substances, and crosstalk between tissues, but also the shortcomings of current knowledge. Summary: Anaemia: Both in healthy and CKD subjects, PE may mimic hypoxia, inhibiting PHDs; so hydroxylate HIF-alpha subunits may be translocated into the nucleus, resulting in dimerization of HIF-1 alpha and HIF-1 beta , recruitment of p300 and CBP, and ultimately, binding to HREs at target genes to cause activation. However, in CKD subjects acute PE causes higher levels of lactate, leading to iron restriction by upregulating hepatic hepcidin expression, while chronic PE allows an increased lactate clearance and HIF-alpha and VEGF alpha levels, stimulating both erythropoiesis and angiogenesis. CKD-MBD: PE may improve bone health decreasing bone resorption and increasing bone formation throughout at least three main pathways: (a) increasing osteoprotegerin and decreasing RANKL system; (b) decreasing cytokine levels; and (c) stimulating production of myokines and adipokines. Key Messages: Future research needs to be defined to develop evidence-based exercise guidance to provide optimal benefit for CKD using exercise interventions as adjuvant therapy for CKD-related complications such as anaemia and CKD-MBD. (c) 2024 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:812 / 820
页数:9
相关论文
共 50 条
  • [31] Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder
    Jiang, Jian-Qing
    Lin, Shan
    Xu, Peng-Cheng
    Zheng, Zhen-Feng
    Jia, Jun-Ya
    NEPHROLOGY, 2011, 16 (06) : 588 - 594
  • [32] Identification of differentially expressed miRNAs associated with chronic kidney disease-mineral bone disorder
    Kim, Kyung Im
    Jeong, Sohyun
    Han, Nayoung
    Oh, Jung Mi
    Oh, Kook-Hwan
    Kim, In-Wha
    FRONTIERS OF MEDICINE, 2017, 11 (03) : 378 - 385
  • [33] Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?
    Cozzolino, Mario
    Urena-Torres, Pablo
    Vervloet, Marc G.
    Brandenburg, Vincent
    Bover, Jordi
    Goldsmith, David
    Larsson, Tobias E.
    Massy, Ziad A.
    Mazzaferro, Sandro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (10) : 1815 - 1820
  • [34] Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives
    Waziri, Bala
    Duarte, Raquel
    Naicker, Saraladevi
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2019, 12 : 263 - 276
  • [35] Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder
    Goto, Shunsuke
    Komaba, Hirotaka
    Fukagawa, Masafumi
    Nishi, Shinichi
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2013, 3 (05) : 457 - 461
  • [36] Potential for Biomarkers of Chronic Kidney Disease-Mineral Bone Disorder to Improve Patient Care
    Alderson, H. V.
    Ritchie, J. P.
    Green, D.
    Chiu, D.
    Kalra, P. A.
    NEPHRON CLINICAL PRACTICE, 2013, 124 (3-4): : 141 - 150
  • [37] Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations
    Hwang, Eunah
    Choi, Bum Soon
    Oh, Kook-Hwan
    Kwon, Young Joo
    Kim, Gheun-Ho
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2015, 34 (01) : 4 - 12
  • [38] Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?
    Figurek, Andreja
    Spasovski, Goce
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (10) : 1863 - 1870
  • [39] Biological and Clinical Effects of Calciprotein Particles on Chronic Kidney Disease-Mineral and Bone Disorder
    Akiyama, Kenichi
    Kimura, Takaaki
    Shiizaki, Kazuhiro
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
  • [40] Chronic kidney disease-mineral and bone disorder: changing insights form changing parameters?
    Vervloet, Marc G.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (03) : 385 - 389